Skip to content
中文产业新闻精选评分69Chinese source

Scholar Rock肌肉靶向疗法Apitegromab获FDA批准

全球首个SMA肌肉靶向疗法获批上市

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.